Lipitor Is Pound-Wise Versus Generic Zocor, Pfizer IDEAL Cost Study Says
This article was originally published in The Pink Sheet Daily
Executive Summary
When total healthcare costs are considered, atorvastatin is more cost-effective than simvastatin even when Zocor is discounted 50% from its current price, Pfizer analysis says.
You may also be interested in...
Lipitor Gains New Indications For Patients With Established Heart Disease
FDA approves Pfizer’s atorvastatin for five new indications based on the results of the Treating to New Targets trial.
Lipitor Gains New Indications For Patients With Established Heart Disease
FDA approves Pfizer’s atorvastatin for five new indications based on the results of the Treating to New Targets trial.
Statin Comparative Studies Needed, Oregon Drug Effectiveness Review Project Suggests
DERP wants comparative-effectiveness study on LDL-c lowering capabilities and adverse events.